Connect with us

Business

In What States Is Weed Legal Right Now?

Published

on

While some states have fully legalized both the medical and recreational use of cannabis, others only allow medical use, and some still have strict prohibition laws.

Despite federal restrictions on cannabis, many states have made significant strides in legalizing and regulating the plant for medical and recreational purposes.

While not all Americans have access to cannabis, 41 states, Puerto Rico, and the District of Columbia have established medical marijuana programs, with 23 of those states fully legalizing cannabis for adult use or decriminalizing it.

As of November 2022, here is a comprehensive and up-to-date list of the legality of cannabis and its products throughout the United States.

legal marijuana
Photo by Dmitriy83/Getty Images

Alabama: Approved a medical marijuana program in 2021, but as of June 2022, there were no doctors certified to issue prescriptions, no licensed dispensaries, and no legal farming of cannabis products.

Alaska: Legalized medical marijuana in 1998, and since 2015, it has been legal to possess and sell cannabis in the state.

Arizona: legal medical marijuana since 2010, and recreational marijuana will become legal once a legalization measure overwhelmingly passed in the 2020 elections is certified.

Arkansas: Only allows medical marijuana, and cultivation is not legal.

California: The first state to legalize medical marijuana in 1996, and the sale of recreational marijuana was approved by voters in 2016.

Colorado: Legalized recreational cannabis in 2012, and it is also legal to privately grow up to six marijuana plants in the state.

Connecticut: Legalized recreational cannabis on July 1, 2021, and allows home cultivation beginning on July 1, 2023.

Delaware: Decriminalized marijuana in 2015 and legalized medical marijuana in 2011, but only a bill to legalize recreational marijuana sales cleared its first legislative hurdle in 2019.

Florida: Allows medical marijuana but not recreational, and Georgia only allows low-THC oil as part of its limited medical program.

Hawaii: Decriminalized recreational marijuana in 2019 and legalized medical marijuana.

Illinois: Legalized both medical and recreational cannabis, with the state legislature passing the law rather than a ballot initiative.

Iowa: Limited medical cannabis program with only processed cannabis products allowed for sale, while

marijuana legalization
Photo by RODNAE Productions via Pexels

Louisiana: Approved medical marijuana, but only allows certain forms of cannabis for purchase. Maine legalized recreational cannabis in 2016, but retail stores have yet to open.

Maryland: Recently became the 20th state to legalize recreational cannabis, with the program set to go into effect in July 2023, while medical marijuana has been legal in the state since 2014.

Massachusetts: Legal for both medical and recreational use; no reciprocity with other states; adults can grow up to 12 plants.

Michigan: Legal for both medical and recreational use; reciprocity with other states; adults can privately grow up to 12 plants.

Minnesota: Legal for medical use only; possession of small amounts is decriminalized; no reciprocity with other states; no home cultivation allowed.

Mississippi: Legal for medical use only; no operational program yet; limited reciprocity with other states; recreational use is illegal; possession of small amounts is decriminalized for first offense only.

Missouri: Legal for both medical and recreational use; no reciprocity with other states; sales for recreational use expected to start in December 2022.

Montana: Legal for both medical and recreational use; no reciprocity with other states; residents can grow up to four plants at home.

Nevada: Legal for both medical and recreational use; reciprocity with other states; medical patients can grow up to 12 plants.

marijuana legalization
Photo by FatCamera/Getty Images

New Hampshire: Legal for medical use only; possession of small amounts is decriminalized; reciprocity with other states; cultivation is illegal.

New Jersey: Legal for both medical and recreational use; no reciprocity with other states.

New Mexico: Legal for both medical and recreational use; reciprocity with other states; home cultivation is allowed for up to six mature plants.

New York: Legal for both medical and recreational use; no reciprocity with other states; public consumption allowed in some places.

North Dakota: Decriminalized marijuana possession and approved medical marijuana, while Ohio and

Pennsylvania: Approved medical marijuana and decriminalized possession.

Oklahoma: Approved medical marijuana and allows patients to grow their plants.

Oregon: Legalized legalized both medical and recreational marijuana and allows residents to grow their plants.

Rhode Island: Legalized both medical and recreational marijuana, and retail sales are expected to begin soon.

South Dakota: Approved medical marijuana but recreational use remains illegal after a challenge from the Governor.

legal marijuana
Photo by Baris-Ozer/Getty Images

Texas: Limited medical programs and possession are illegal except for those with medical permits.

Utah: Approved medical marijuana and decriminalized recreational use.

Vermont: Legalized both medical and recreational marijuana and allows residents to cultivate their plants

Virginia: Allows both medical and recreational cannabis use, with a possession limit of up to 1 ounce for adults.

Washington: One of the first states to legalize recreational cannabis, with medical cannabis also legal.

West Virginia: Medical cannabis is legal, but recreational use is not.

Washington DC: Allows medical cannabis and possession of up to 2 ounces of recreational cannabis, but the sale of recreational cannabis is still illegal.

Conclusion

As we have seen, the legal status of cannabis varies greatly across different states in the US. While some states have fully legalized both the medical and recreational use of cannabis, others only allow medical use, and some still have strict prohibition laws. However, the tide is turning, with more and more states moving towards legalization in some form.

As attitudes towards cannabis continue to shift and more research is conducted on its potential benefits and drawbacks, it will be interesting to see how these laws evolve in the future. Whatever happens, cannabis will continue to be a hotly debated topic in the US and around the world for many years to come.

Source: https://thefreshtoast.com/cannabis/in-what-states-is-weed-legal-right-now/

Business

Jio’s 1,600-Satellite LEO Constellation Gets Technical Green Light

Published

on

By

Reliance Jio has crossed a significant milestone in its space connectivity ambitions after its proposal to deploy a Low Earth Orbit (LEO) satellite constellation of around 1,600 satellites received a positive technical assessment from the Indian National Space Promotion and Authorisation Centre (IN-SPACe).

The evaluation, conducted jointly by IN-SPACe, the Indian Space Research Organisation (ISRO), and the Wireless Planning and Coordination (WPC) wing of the Department of Telecommunications, reportedly concluded that Jio’s proposed system meets the required technical standards and is comparable to leading global satellite broadband networks.

India’s Indigenous LEO Satellite Vision

Under the proposal, Reliance Jio plans to deploy between 1,600 and 1,650 satellites in Low Earth Orbit at an altitude of around 650 kilometres.

The planned constellation is expected to provide high-speed satellite connectivity across India, with approximately 32 satellites visible from any location at a given time. The company aims to roll out the network within the next two to three years, subject to regulatory approvals.

According to industry estimates, the satellite system could deliver 4.5 to 5 terabits per second (Tbps) of total data capacity, making it one of the largest satellite broadband projects proposed in India.

The project is expected to require an investment of $10–15 billion (approximately ₹95,000 crore to ₹1.42 lakh crore), reflecting the scale of infrastructure needed for satellite manufacturing, launches, ground stations, and user terminals.

Regulatory Process Moves Forward

Following the successful technical review, the proposal is expected to move into the next phase of regulatory approvals.

The government may now assist Jio in securing orbital slots, coordinating spectrum usage, and filing applications with the International Telecommunication Union (ITU), the global body responsible for managing satellite orbit and frequency allocations.

Obtaining orbital rights remains a critical step, as Low Earth Orbit has become increasingly competitive due to the growing number of satellite broadband projects being planned worldwide.

Officials also indicated that the proposed satellite architecture has been designed to coexist with future Indian LEO constellations, allowing multiple domestic operators to share orbital resources efficiently.

Broadband, Mobile Connectivity, and Strategic Applications

Jio plans to use the satellite network to provide a range of communication services, including satellite broadband, mobile backhaul, enterprise connectivity, and direct-to-device (D2D) satellite communication, particularly in remote and underserved regions where conventional telecom infrastructure is limited.

The company also intends to establish 20 to 22 ground stations across India to support network operations.

Apart from commercial telecommunications, officials have highlighted the project’s potential strategic importance. A domestically developed satellite constellation could strengthen India’s communication infrastructure, reduce dependence on foreign satellite operators, and support national security requirements.

Reports suggest preliminary discussions are underway regarding the possibility of integrating defence-related payloads into some satellites, enabling both civilian and strategic use.

Major Step for India’s Space and Telecom Sectors

Industry analysts view the technical clearance as an important milestone in India’s expanding private space ecosystem. If Jio secures the remaining regulatory approvals and international orbital clearances, the project could become the country’s first large-scale indigenous LEO satellite broadband network.

The initiative also aligns with India’s broader efforts to expand digital connectivity while strengthening its presence in the global satellite communications market.

Continue Reading

Business

Alleged Crores Pharma Scam Mastermind Arrested from Surat

Published

on

By

After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.

Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.

Fake Business Deals and Dishonoured Cheques Used in Fraud

Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.

In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”

Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.

Multiple Identities and Repeated Fraud Pattern

Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.

Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.

Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.

Multi-State Surveillance Leads to Arrest in Surat

A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.

Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.

Growing Threat of Corporate Identity Fraud

The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.

Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.

Experts Urge Stronger Due Diligence in High-Value Transactions

Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.

Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.

Continue Reading

Business

EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices

Published

on

By

A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.

Investigation Under Digital Markets Act Gains Momentum

The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.

Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.

Industry Groups Demand Swift Action

Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.

Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.

In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.

Google Denies Allegations

Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.

However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.

Potential Billion-Euro Penalties

If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.

Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.

Wider Implications for Big Tech

The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.

A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.

As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News